4 October 2016
Invent Farma and neuraxpharm appoint new group CEO
Following the acquisitions of Invent Farma and neuraxpharm by funds advised by Apax Partners, Stephan Walz has been appointed Chief Executive Officer. He will assume the newly-created role of Group CEO and will be leading Invent Farma’ and neuraxpharm’s activities across all markets.